| Autor: |
Johri, Nishant, Matreja, Prithpal S., Agarwal, Shalabh, Nagar, Priya, Kumar, Deepanshu, Maurya, Aditya |
| Zdroj: |
Journal of Cardiovascular Translational Research; Apr2024, Vol. 17 Issue 2, p345-355, 11p |
| Abstrakt: |
Ischemic heart disease, which results from plaque formation in the coronary arteries, hinders the flow of oxygenated blood to the heart, leading to ischemia. Reperfusion injury remains a significant challenge for researchers, and the mechanisms underlying myocardial ischemia–reperfusion injury (MIRI) are not entirely understood. The review directs future research into potential targets in clinical treatment based on our present understanding of the pathophysiological mechanisms of MIRI. The study provides insights into the mechanisms underlying MIRI and offers direction for future research in this area. The use of targeted therapies may hold promise in improving cardiac function in the elderly and minimizing the adverse effects of revascularization therapies. The purpose of this review is to analyze the role of activated protein C (APC) in the pathogenesis of ischemic heart disease, heart failure, and myocardial ischemia–reperfusion injury, and discuss the potential of APC-based therapeutics. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Full text from SpringerLink